Gene test before kidney transplant could prevent rejection and save money

NCT ID NCT06701825

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 29 times

Summary

This study tests whether doing a genetic test before a kidney transplant can help doctors choose the best starting dose of tacrolimus, an anti-rejection drug. About 114 adults waiting for a kidney transplant will be randomly assigned to either standard care or the genetic-testing approach. The goal is to see if more patients reach the ideal drug level in their blood by day 4 after transplant, and whether this strategy is cost-effective for the Spanish health system.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY DISEASE, CHRONIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital La Paz

    RECRUITING

    Madrid, Madrid, 28046, Spain

    Contact

Conditions

Explore the condition pages connected to this study.